How Wearable Insulin Patches Are Replacing Injections

Lucas and Luna explore how wearable insulin patches are changing diabetes management in mid-2026. They focus on the specific case of the Beta Bionics iLet pump with the new SAGE continuous glucose monitor integration, which recently received FDA clearance for a fully closed-loop system. The hosts discuss real-world data from a 12-month trial showing a 1.8 percentage point improvement in time-in-range for Type 1 diabetes patients using the patch versus multiple daily injections. They also compare it to competitors like the Medtronic MiniMed 780G and the Omnipod 5, and touch on the cost barrier: about $500 per month for the patch system versus $300 for traditional insulin pens. The episode closes with a reflection on whether wearables are truly democratizing chronic care or creating a two-tier system. #WearableTech #InsulinPatch #DiabetesCare #ClosedLoop #BetaBionics #iLet #SAGE #CGM #Medtronic #MiniMed780G #Omnipod5 #TimeInRange #FDA #Type1Diabetes #ChronicCare #WearableDevices #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo